Synthesis and pharmacological evaluation of novel non-lactone analogues of camptothecin

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 16, 2003, Pages 2731-2735

  Hautefaye, Patrick ^a   Cimetière, Bernard ^a   Pierré, Alain ^a   Léonce, Stéphane ^a   Hickman, John ^a   Laine, William ^b   Bailly, Christian ^b   Lavielle, Gilbert ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN DERIVATIVE; DNA TOPOISOMERASE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CATALYSIS; CONTROLLED STUDY; CYTOTOXICITY; DNA CLEAVAGE; DRUG DESIGN; DRUG SYNTHESIS; ENZYME INHIBITION; IC 50; MOUSE; NONHUMAN;

EID: 0038149018     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00534-1     Document Type: Article

References (21)

1. Presented in part at the XVIIth International Symposium on Medicinal Chemistry, Sept. 1-5, 2002, Barcelona, Spain; P279.
2. Wall M.E., Wani M.C., Cook C.E., Palmer K.H., McPhail A.T., Sim G.A. J. Am. Chem. Soc. 88:1966;3888.
3. Hsiang Y.H., Hertzberg R.P., Hecht S., Liu L.F. J. Biol. Chem. 260:1985;14873.
4. Fan Y., Weinstein J.N., Kohn K.W., Shi L.M., Pommier Y. J. Med. Chem. 41:1998;2216.
5. Redinbo M.R., Stewart L., Kuhn P., Champoux J.J., Hol W.G.J. Science. 279:1998;1504.
6. Staker B.L., Hjerrild K., Feese M.D., Behnke C.A., Burgin A.B. Jr., Stewart L. Proc. Natl. Acad. Sci. U.S.A. 99:2002;15387.
7. For a recent review, see: Du W., Curran D.P., Bevins R.L., Zimmer S.G., Zhang J., Burke T.G. Bioorg. Med. Chem. 10:2002;103.
8. Lavergne O., Lesueur-Ginot L., Pla Rodas F., Kasprzyk P.G., Pommier J., Demarquay D., Prevost G., Ulibarri G., Rolland A., Schiano-Liberatore A.-M., Harnett J., Pons D., Camara J., Bigg D.C.H. J. Med. Chem. 41:1998;5410.
9. Lavergne O., Lesueur-Ginot L., Pla Rodas F., Bigg D.C.H. Bioorg. Med. Chem. Lett. 7:1997;2235.
10. Bailly C. Crit. Rev. Oncol. Hematol. 45:2003;91.
11. Comins D.L., Baevsky M.F., Hong H. J. Am. Chem. Soc. 114:1992;10971.
12. Rocca P., Cochennec C., Marsais F., Thomas-dit-Dumont L., Mallet M., Godard A., Queguiner G. J. Org. Chem. 58:1993;7832.
13. Comins D.L., Saha J.K. Tetrahedron Lett. 36:1995;7995.
14. Liu H., Ko S.B., Josien H., Curran D.P. Tetrahedron Lett. 36:1995;8917.
15. 2, the different quinolines were obtained from: Meth-Cohn O., Narine B., Tarnoruski B. J. Chem. Soc., Perkin Trans 1. 1981;1520 Meth-Cohn O., Narine B. Tetrahedron Lett. 23:1978;2045 Bigg, D. C. H.; Lavergne, O.; Pla Rodas, F.; Pommier, J.; Ulibarri, G. WO Patent 9700876; Chem. Abstr. 1997, 126, 144433.
16. 2, the different quinolines were obtained from: Meth-Cohn O., Narine B., Tarnoruski B. J. Chem. Soc., Perkin Trans 1. 1981;1520 Meth-Cohn O., Narine B. Tetrahedron Lett. 23:1978;2045 Bigg, D. C. H.; Lavergne, O.; Pla Rodas, F.; Pommier, J.; Ulibarri, G. WO Patent 9700876; Chem. Abstr. 1997, 126, 144433.
17. 2, the different quinolines were obtained from: Meth-Cohn O., Narine B., Tarnoruski B. J. Chem. Soc., Perkin Trans 1. 1981;1520 Meth-Cohn O., Narine B. Tetrahedron Lett. 23:1978;2045 Bigg, D. C. H.; Lavergne, O.; Pla Rodas, F.; Pommier, J.; Ulibarri, G. WO Patent 9700876; Chem. Abstr. 1997, 126, 144433.
18. Kaiser E.M., Petty J.D. Synthesis. 1975;705.
19. Bailly C. Methods Enzymol. 340:2001;610.
20. L1210 cells were cultivated in RPMI 1640 medium (Gibco) supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 units/mL penicillin, 100 μg/mL streptomycin, and 10 mM HEPES buffer (pH=7.4). For details: Costes N., LeDeit H., Michel S., Tillequin F., Koch M., Pfeiffer B., Renard P., Léonce S., Guilbaud N., Kraus-Berthier L., Pierré A., Atassi G. J. Med. Chem. 43:2000;2395.
21. 5 cells/mL) were incubated for 21 h with various concentrations of the drugs. Cells were then fixed by 70% ethanol, and analyzed on a XL/MCL flow cytometer (Beckman Coulter, France).